Search results
Epstein-Barr virus: how does a common infection trick the immune system into attacking the brain in...
The Conversation· 14 hours agoAlmost 3 million people worldwide have multiple sclerosis (MS) – an autoimmune disease caused by the immune system mistakenly attacking the brain and central nervous system. While treatments ...
Multiple sclerosis: Can dietary choices influence risk?
Medical News Today· 5 days agoExperts have yet to understand why multiple sclerosis (MS) develops, but current research suggests...
Mark Cavendish knighted in King's Birthday Honours ahead of final Tour de France
Cyclingnews· 4 days agoCycling’s best-ever sprinter Mark Cavendish has been knighted and will take aim at a record 35th...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 7 days agoMolecular, genetic, and cellular analyses showed the two lymphomas had distinct immunophenotypes and...
What Is a T-Cell Lymphoproliferative Disorder? Inside Halsey's Diagnosis
Health.com· 6 days agoHalsey, 29, was diagnosed and treated for both lupus and a rare white blood cell disorder, according...
Advice | What the latest science says about Lyme disease
Washington Post· 1 day agoLyme disease is a bacterial infection that spreads through tick bites. It may cause flu-like symptoms and a bull’s-eye-shaped rash. Most people fully recover after a few weeks of antibiotic ...
Case Study: Sudden Blurred Vision in a Young Woman
MedPage Today· 6 days ago"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. "Medical Journeys" chart a ...
Post-viral arthritis: Causes, symptoms, and treatments
Medical News Today· 5 days agoViral arthritis is an uncommon form of arthritis that occurs following a viral infection. It can...
Atara Biotherapeutics (NASDAQ:ATRA) Shares Scheduled to Reverse Split on Thursday, June 20th
ETF DAILY NEWS· 16 hours agoAtara Biotherapeutics, Inc. (NASDAQ:ATRA – Free Report) shares are scheduled to reverse split on the morning of Thursday, June 20th. The 1-25 reverse split was announced on Thursday, June 20th ...
Oppenheimer Increases Moderna (NASDAQ:MRNA) Price Target to $179.00
ETF DAILY NEWS· 5 days agoModerna (NASDAQ:MRNA – Get Free Report) had its target price hoisted by analysts at Oppenheimer from $163.00 to $179.00 in a research report issued to clients and investors on Wednesday, Benzinga ...